114 related articles for article (PubMed ID: 21653768)
1. Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.
Ross JE; Liverman LC; Jones RN
J Clin Microbiol; 2011 Aug; 49(8):3009-11. PubMed ID: 21653768
[TBL] [Abstract][Full Text] [Related]
2. Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.
Ross JE; Scangarella-Oman N; Jones RN
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):437-9. PubMed ID: 23461830
[TBL] [Abstract][Full Text] [Related]
3. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
[TBL] [Abstract][Full Text] [Related]
4. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
5. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program.
Farrell DJ; Liverman LC; Biedenbach DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):415-20. PubMed ID: 21982563
[TBL] [Abstract][Full Text] [Related]
7. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
Odland BA; Erwin ME; Jones RN
J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
[TBL] [Abstract][Full Text] [Related]
8. Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia.
Biedenbach DJ; Farrell DJ; Flamm RK; Liverman LC; McIntyre G; Jones RN
Int J Antimicrob Agents; 2012 Apr; 39(4):321-5. PubMed ID: 22306239
[TBL] [Abstract][Full Text] [Related]
9. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
[TBL] [Abstract][Full Text] [Related]
10. Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent.
Ross JE; Scangarella-Oman NE; Flamm RK; Jones RN
J Clin Microbiol; 2014 Jul; 52(7):2629-32. PubMed ID: 24759716
[TBL] [Abstract][Full Text] [Related]
11. Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.
Farrell DJ; Turner LL; Castanheira M; Jones RN
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):73-4. PubMed ID: 22819242
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Morrow BJ; He W; Amsler KM; Foleno BD; Macielag MJ; Lynch AS; Bush K
Antimicrob Agents Chemother; 2010 May; 54(5):1955-64. PubMed ID: 20176911
[TBL] [Abstract][Full Text] [Related]
13. Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.
Bale MJ; Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1994 May; 19(1):65-8. PubMed ID: 7956017
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
Brown SD; Traczewski MM
J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
[TBL] [Abstract][Full Text] [Related]
15. Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.
Ross JE; Sader HS; Ivezic-Schoenfeld Z; Paukner S; Jones RN
J Clin Microbiol; 2012 Oct; 50(10):3361-4. PubMed ID: 22814462
[TBL] [Abstract][Full Text] [Related]
16. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
[TBL] [Abstract][Full Text] [Related]
17. Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains.
Biedenbach DJ; Turner LL; Jones RN; Farrell DJ
Diagn Microbiol Infect Dis; 2012 Oct; 74(2):204-6. PubMed ID: 22819604
[TBL] [Abstract][Full Text] [Related]
18. JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.
Farrell DJ; Liverman LC; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 2011 Jul; 55(7):3631-4. PubMed ID: 21555765
[TBL] [Abstract][Full Text] [Related]
19. Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
Barry AL; Fuchs PC; Allen SD; Tenover FC; Jorgensen JH; Reller LB
J Clin Microbiol; 1995 Jan; 33(1):235-8. PubMed ID: 7699050
[TBL] [Abstract][Full Text] [Related]
20. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.
Koeth LM; Matuschek E; Kahlmeter G; Stone G
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1047-1053. PubMed ID: 29603034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
